Literature DB >> 6423822

Lithium and symptomatic hyperparathyroidism.

J Ananth, S E Dubin.   

Abstract

Hyperparathyroidism with or without adenoma has occasionally been reported in association with lithium treatment, and in symptomatic patients depression, psychosis and an exacerbation of existing psychopathology may occur. Three lithium-treated patients with hyperparathyroidism are reported, in whom discontinuation of lithium in one and removal of parathyroid adenomata in two led to both a reduction in plasma calcium levels and an improvement in their psychopathology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6423822      PMCID: PMC1439526          DOI: 10.1177/014107688307601210

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  18 in total

1.  Hypothyroidism and hyperparathyroidism associated with lithium.

Authors:  P E Garfinkel; C Ezrin; H C Stancer
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

2.  Non-autonomy of hormone secretion in primary hyperparathyroidism.

Authors:  T M Murray; M Peacock; D Powell; J M Monchik; J T Potts
Journal:  Clin Endocrinol (Oxf)       Date:  1972-07       Impact factor: 3.478

3.  Hypercalcaemia in thyrotoxicosis with and without hyperparathyroidism.

Authors:  A J Richards
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

4.  Endocrine effects of lithium: II. 'Primary' hyperparathyroidism.

Authors:  C Christiansen; P C Baastrup; P Lindgreen; I Transbøl
Journal:  Acta Endocrinol (Copenh)       Date:  1978-07

5.  Hyperparathyroidism: therapy and response, with a test for assessment of response.

Authors:  R E Goldsmith; E A Gall; W A Altemeier; A Weinstein; E Zalme
Journal:  Ann Intern Med       Date:  1971-09       Impact factor: 25.391

6.  Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism.

Authors:  C Christiansen; P C Baastrup; I Transbol
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

7.  Hyperthyroidism and a parathyroid adenoma complicating lithium treatment.

Authors:  G A MacGregor
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

8.  Letter: Lithium, hypercalcaemia, and hyperparathyroidism.

Authors:  T A Christensson
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

9.  Lithium-carbonate-induced hypercalcemia.

Authors:  S J Cervi-Skinner
Journal:  West J Med       Date:  1977-12

10.  Mechanism of lithium-induced hypercalciuria in rats.

Authors:  K Lau; S Goldfarb; M Grabie; Z S Agus; M Goldberg
Journal:  Am J Physiol       Date:  1978-03
View more
  6 in total

1.  Chronic lithium intake and hyperparathyroidism.

Authors:  A Prasad
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Persistent nephrogenic diabetes insipidus, hyperparathyroidism, and hypothyroidism after lithium treatment.

Authors:  S R Cairns; R Wolman; J G Lewis; R Thakker
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

3.  Hypercalcaemia. What does it signify?

Authors:  R A Evans
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

Review 4.  Lithium therapy and hyperparathyroidism: an evidence-based assessment.

Authors:  Brian D Saunders; Erika F H Saunders; Paul G Gauger
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

5.  Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study.

Authors:  Bas A Twigt; Bernard M Houweling; Menno R Vriens; Eline J Regeer; Ralph W Kupka; Inne Hm Borel Rinkes; Gerlof D Valk
Journal:  Int J Bipolar Disord       Date:  2013-09-16

6.  No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.

Authors:  A Kieninger-Gräfitsch; S Vogt; C Ribi; D Dubler; C Chizzolini; U Huynh-Do; M Osthoff; M Trendelenburg
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.